Previous Article | Next Article 
Journal of Clinical Microbiology, October 2001, p. 3491-3494, Vol. 39, No. 10
Department of Dermatology, Juntendo
University School of Medicine, 2-1-1 Hongo, Bunko-ku, Tokyo 113, Japan
Received 18 December 2000/Returned for modification 3 May
2001/Accepted 31 July 2001
The LightCycler system (two-step reverse
transcription-PCR-fluorescent hybridization [LC RT-PCR-FH])
was used to quantify Candida albicans actin mRNA as a
means of assessing its viability in a reconstituted skin model of
cutaneous candidiasis following the application of an antimycotic. A
192-bp ACT exon fragment was ligated into the pCR2.1
plasmid vector, and dilutions of the cloned insert (pACT; 4.092 kb)
were used as the standard reference template. The LC RT-PCR-FH system
could detect 1 fg of pACT, equivalent to 2.2 copies of the plasmid. The
ACT exon-based PCR primers and FH probes were C.
albicans specific, and electrophoretic analysis of the LC
RT-PCR-FH assay product showed a 174-bp band in agarose gel. The
number of copies of C. albicans ACT mRNA per milligram of tissue decreased with increasing amounts of amorolfine applied to a
C. albicans-infected skin model, showing a reduction in
viability. Detection and quantification of ACT mRNA in
tissue by the LC RT-PCR-FH assay corresponded with cultural isolation
of C. albicans from samples. The ACT
mRNA-targeted LC RT-PCR-FH assay represents a sensitive, specific,
rapid, and quantitative means of assessing the viability of C.
albicans in infected tissue. This method may also be useful in
evaluating the therapeutic efficacies of antifungal drugs in the
treatment of various forms of candidiasis and other fungal diseases.
Candida species are
frequently found as saprophytes that colonize the surfaces of certain
mucous membranes in human. The superficial and disseminated infections
caused by them are largely opportunistic, and Candida
albicans accounts for most of the etiologic species isolated from
cutaneous candidiasis. Microscopic demonstration of yeast elements in
potassium hydroxide preparations of infected tissue and cultural
isolation of yeast from skin scrapings are used to confirm clinical
diagnosis of cutaneous candidiasis. Rapid and highly sensitive
diagnostic assays, based on PCR of DNA, have also been used to identify
candidal pathogens in tissue (3, 4, 5, 7, 8).
The amplification of a targeted DNA sequence by PCR does not, however,
indicate the viability of the source organism, important information
for evaluating the efficacy of a particular therapy and thus for
avoiding an unnecessary prolongation of therapy. For this reason,
reverse transcription (RT)-PCR of mRNA molecules has been used to
assess the viability of microorganisms (9, 11, 14).
However, RT-PCR is a qualitative assay, and this places a limitation on
the inferences that can be drawn from the result; differences in the
quantities of target mRNAs cannot easily be ascertained from the
intensities of amplification bands. A determination of quantitative
differences is needed in an assessment of the potencies of different
concentrations of an agent or the progressive efficacy of a particular
treatment. Furthermore, with the template at low levels, bands are
seldom visualized in gel, resulting in false-negative interpretations
(14).
In this study, we estimated the viability of C. albicans in
a reconstituted-skin model of cutaneous candidiasis by detection of
C. albicans ACT mRNA using the LightCycler (LC) system (a
two-step RT-PCR-fluorescent hybridization [FH] assay)
(10). LC DNA-based identification of fungi has been shown
to be highly sensitive and rapid (10), and we applied of
this system to rapidly quantify C. albicans ACT mRNA. The
ACT mRNA was specifically targeted because of the
constitutive nature of the gene and the major role of actin in cell
division (6, 15).
Materials.
An isolate of C. albicans
(serotype A; JUH 3181) was used. The isolate was obtained from the
Juntendo University Hospital culture collection. Amorolfine powder was
a gift from Kyorin Pharmaceutical Co. Ltd. (Tokyo, Japan).
Isolation of fungal total RNA.
A single C. albicans colony from a 24-h Sabouraud dextrose agar culture was
inoculated into 5 ml of Sabouraud broth. The culture was incubated at
30°C with orbital shaking for 18 h. The yeast cells were
harvested by centrifugation at 3,000 × g and 4°C for 5 min and washed three times in phosphate-buffered saline (PBS). The
cells were homogenized by grinding them with a pellet mixer and then by
passaging them several times through a 23-guage needle. Total RNA was
extracted by the guanidine isothiocyanate-phenol method
(2) using Isogen (Wako Junyaku Kogyo, Osaka, Japan) according to the manufacturer's instructions.
Design of PCR primers and fluorescent hybridization (FH)
probes.
Figure 1 shows a schematic
representation of the C. albicans ACT gene indicating the
target areas of the primers and probes. The primers and probes were
based on the published sequence of the actin genes of C. albicans (GenBank accession no. X16377). The uniqueness of the
primers and probes for C. albicans ACT1 was determined using
the BLAST database search program (1), courtesy of The
Institute for Genomic Research (http://www.tigr.org.).
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.10.3491-3494.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Quantification of Candida albicans
Actin mRNA by the LightCycler System as a Means of Assessing Viability
in a Model of Cutaneous Candidiasis
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
View larger version (5K):
[in a new window]
FIG. 1.
Schematic representation of the intron-containing actin
gene (ACT) fragment of C. albicans showing the
locations of the PCR primers and hybridization probes.
3' (CR; bp 158 to 178).
The upstream primer spanned the exon-exon boundaries of ACT,
thus excluding the amplification of genomic DNA. The FH probes,
5'-TAGACCAAGACATCAAGGTATCATGG-3' (H1; bp 87 to 109) and
5'-AGCTGTTTTCCCATCTCTTGTTG-3'(H2; bp 111 to 136), were
respectively labeled at the 5' and 3' ends with LC Red 640 fluorophore
and fluorescein (Roche Diagnostics GmbH, Mannheim, Germany). The former
was also modified at the 3' end by phosphorylation to avoid extension
during PCR. The probes anneal to adjacent internal sequences of the
ACT, 1 bp apart, thus enabling fluorescent resonance energy
transfer between the fluorophores (10).
Preparation of the pACT plasmid, a standard ACT mRNA quantification reference. A 192-bp C. albicans ACT exon fragment containing the target ACT fragment was amplified by RT-PCR (RNA PCR kit; TaKaRa Shuzo Co. Ltd., Ohtsu, Japan) using 5'-ATGGACGGTGAAGAAGTTGC-3' (SF; bp 1 to 20) and 5'-ACCTCTTTTGGATTGGGCTTCA-3' (SR; bp 171 to 192) (Fig. 1). RT was performed with a 20-µl reaction mixture containing 1× RNA PCR buffer (10 mM Tris-HCl, pH 8.3); 50 mM KCl; 250 µM (each) dTTP, dUTP, dATP, and dGTP; 2.5 U of avian myeloblastosis virus reverse transcriptase, 5 mM MgCl2, 20 U of an RNase inhibitor, and a 0.125 µM concentration of the oligo(dT) adapter nucleotide primer. RT was performed in a DNA thermal cycler (model 480; Perkin-Elmer, Norwalk, Conn.) with one cycle of 30°C for 10 min, 50°C for 30 min, 99°C for 5 min, and 4°C for 5 min.
PCR was performed in the same tube, with the final 100-µl reaction mixture containing 1× RNA PCR buffer, 2.5 mM MgCl2, 2.5 U of Taq polymerase, and a 20 pM concentration of each of the primers SF and SR. PCR was performed in a DNA thermal cycler with 1 cycle of 5 min at 95°C; 30 cycles of 1 min at 95°C, 30 s at 62°C, and 30 s at 72°C; and a final extension at 72°C for 5 min. Amplification products were separated by electrophoresis through 1.5% (wt/vol) agarose gel containing 0.5 µg of ethidium bromide/ml. The band of the amplification product of the expected size was cut from the gel and purified using a MERmaid kit (Bio 101 Inc., Vista, Calif.) as instructed by the manufacturer. The amplicon was sequenced using the PCR primers and a dRhodamine terminator cycle sequencing kit (Perkin-Elmer) according to the manufacturer's instructions. Sequence analysis was performed on an ABI PRISM 310 genetic analyzer (Perkin-Elmer). The 192-bp ACT exon fragment was ligated into the pCR 2.1 plasmid vector (3.9 kb) and transformed into One Shot cells (INV
F') using a TA cloning kit (Invitrogen Corp., Carlsbad, Calif.) as instructed by the manufacturer. Dilutions of the plasmid containing the
cloned insert (pACT; 4.092 kb) were then used as the standard reference
templates for detection and quantification of ACT mRNA by
the LC RT-PCR-FH assay.
Sensitivity of the LC RT-PCR-FH system. The template, pACT, was diluted to contain 20 ng, 200 pg, 2 pg, 20 fg, 2 fg, or 1 fg of DNA/µl. The LC RT-PCR-FH assay was performed with a 20-µl reaction mixture in glass capillaries which contained 2 µl of the template, 4 mM MgCl2, a 0.5 µM concentration of each of the PCR primers CF and CR, a 0.2 µM concentration of each of the FH probes H1 and H2, and 1× LC DNA master hybridization mixture (ready-to-use reaction mix containing DNA polymerase). The cycle program data of LightCycler software (version 3; Roche Diagnostics GmbH) were set at 1 cycle of denaturation at 95°C for 2 min; 60 cycles of 95°C for 0 s (once this temperature is reached, it immediately falls to the annealing temperature), annealing at 62°C for 10 s, and extension at 72°C for 7 s; and 1 cycle of cooling at 40°C for 30 s. Other program data were set as instructed by the manufacturers. PCR amplification dynamics were monitored online.
The LC RT-PCR-FH product was recovered from the capillary tubes and separated by electrophoresis on a 1.5% (wt/vol) agarose gel.Specificities of the PCR primers and FH probes in the LC system. The total RNA extracts of C. albicans (ATCC 76615) and the following organisms were used as templates: Candida tropicalis (ATCC 750), Candida krusei (clinical isolate), Aspergillus fumigatus (ATCC 26430), Aspergillus flavus (IFO 7540), Aspergillus niger (IFO 31628), Asperigullus terreus (IFO 31675), Cryptococcus neoformans (TIMM 3173), Trichosporon beigelli (clinical isolate), Trichosporon mucoides (clinical isolate), Microsporum canis (IFM 47138), Epidermophyton floccosum (ATCC 50266), Trichophyton mentagrophytes (IFM 45795), Trichophyton rubrum (IFM 47168), Sporothrix schenckii (clinical isolate), Nocardia asteroides (clinical isolate), Staphylococcus epidermidis (ATCC 14970), and Streptococcus sanguis (ATCC 10556). Total RNA extract of human keratinocytes was also used as a template. RT was performed, and the product was assayed by the LC RT-PCR-FH method as described above.
Infection of a reconstituted human skin model with C. albicans. The reconstituted skin (Testskin; Toyobo Co. Ltd., Tokyo, Japan) consisted of human dermal fibroblasts in a collagen lattice overlaid by stratified human keratinocytes. Six wells of the model were set up as instructed by the manufacturer. The inoculum, C. albicans, was cultured in Sabouraud broth and adjusted to a density of 2 × 103 cells per ml of PBS. Fifty microliters of the C. albicans suspension was inoculated onto the skin surface in each of five wells. Fifty microliters of PBS was applied to the sixth skin model as a negative infection control. The skin model was maintained in serum-free Testskin assay medium (Toyobo Co. Ltd.) at 37°C for 48 h in an atmosphere of 5% CO2-95% O2.
Five, 10, 20, or 40 µg of amorolfine, in a 50-µl PBS solution, was applied to the surfaces of four C. albicans-infected skin models at 48 and 96 h postinfection, and the tissue maintenance medium was replaced with a fresh medium containing 5 µg of amorolfine/ml. Fifty microliters of PBS was also applied to the positive- and negative-infection control skin models, and the tissue maintenance medium was drug free in both cases. At 6 days postinfection, a 6-mm-diameter portion of skin was excised with a punch and the total RNA content was extracted. The remaining portion was inoculated on Sabouraud agar.Extraction of total RNA from the skin model and quantification of C. albicans ACT mRNA. The skin fragment was weighed, minced, and suspended in 500 µl of 10 mM Tris-HCl buffer (pH 7.8) containing 1 mM CaCl2O·2H2O, 10 mM dithiothreitol, 20 U of an RNase inhibitor, and 500 µg of proteinase K. The mixture was incubated at 37°C for 45 min and then centrifuged for 3 min at 3,000 × g and 4°C. The precipitate was washed once in 1 ml of chelating buffer containing 10 mM Tris-HCl (pH 7.8) and 2 mM EGTA and then suspended in 1 ml of Isogen (Wako Junyako Kogyo Ltd.). Total RNA was extracted as described earlier.
RT was performed as described above, and a negative control, which contained water in place of reverse transcriptase, was included for each sample. The RT product and 106, 105, and 104 copies of pACT/µl were then used as templates in the LC RT-PCR-FH. Postamplification analysis was carried out with LC data analysis software (version 3.1.102; Roche Diagnostics GmbH), and the copy number of the template was determined. The concentration of C. albicans ACT mRNA, in copy number per milligram of skin, was then calculated using the following formula: (copy number of the ACT cDNA template in the test reaction mixture background quantity in the control reaction mixture) × dilution
factor of RT reaction mixture × volume of total RNA extract/mass
of skin fragment (in milligrams).
The LC RT-PCR-FH products were recovered from the capillary tubes,
electrophoresed on a 1.5% (wt/vol) agarose gel, and purified. Both
strands of the purified product were sequenced as described above using
the PCR primers.
| |
RESULTS |
|---|
|
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
|
|---|
Sensitivity of the LC RT-PCR-FH system.
Amplification of
different concentrations of pACT was monitored online by
regular-log-fluorescence versus cycle number curves (Fig.
2). The irregular curve below the noise
band cursor indicated nonamplification of the negative control (water).
The system could detect 1 fg of pACT, and this number was equivalent to
2.2 copies of pACT. The calculation of the copy number was as described
elsewhere (15): 1 mol of 4,092-bp pACT has a mass of
2.7 × 106 g, and 1 fg of pACT contains
3.7 × 10
24 mol. Multiplying this number
by Avogadro's number, 6 × 1023, gives the
stated copy number. Figure 3 shows the
results of agarose gel electrophoresis of the amplification products
from the pACT concentrations.
|
|
Specificity.
The ACT-based PCR primers and FH
probes were specific for C. albicans as indicated by
regular-log-fluorescence versus cycle number curves (not shown). The
negative control, reference organisms, and human templates were not
amplified, as is indicated by irregular curves below the noise band
cursor. Electrophoresis of the LC RT-PCR-FH products showed a single
band for the amplification product of the expected size of 174 bp from
C. albicans; no band was observed in the reaction product of
the reference organisms and human keratinocytes (Fig.
4).
|
|
| |
DISCUSSION |
|---|
|
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
|
|---|
Routine qualitative RT-PCR assay has been used in assessing the viability of microorganisms by targeting the heat shock protein 70 mRNAs of Pneumocystis carinii (11), Giardia cysts, and Cryptosporidium oocysts (9) and the actin mRNA of C. albicans (14). In this study, we quantified C. albicans actin mRNA as a means of assessing the viability of C. albicans in a reconstituted-human-skin model of cutaneous candidiasis following the application of the antimycotic. Amorolfine was used because of its effectiveness in the topical therapy of superficial mycoses caused by yeasts and dermatophytes and its high affinity to stratum corneum and nails (12, 13).
The two-step LC RT-PCR-FH system was used to detect and quantify mRNA. The system combines rapid PCR-FH in glass capillaries with online fluorescence detection of the hybridized PCR amplicon (10). We further developed a method for calculating the number of copies of C. albicans ACT mRNA per milligram of the infected skin. The sense PCR primer was designed to span an intron splice site, thus ensuring the amplification of only the reverse transcripts of the ACT mRNA.
The LC system proved itself extremely sensitive in detecting 1 fg of the standard plasmid online, with a reproducibility of 100% among five replicates. In contrast, the LC PCR products of 2 or 1 fg of pACT did not show any visible band on an electrophoretic gel (Fig. 3). This result showed that detection of amplicons by means of FH in the LC system was more sensitive than visual observation of amplicon bands in gels. Thus, the LC system has sufficient sensitivity to detect ACT mRNA expressed from a single genome of C. albicans comparable to that reported for the 5' nuclease TaqMan PCR assay (16). Although the extreme sensitivity of the system may not be a priority in cutaneous candidiasis, our model has conveniently demonstrated that this system is applicable to other mycoses provided that the appropriate primers and hybridization probes are used.
The PCR primers and FH probes, based on the ACT exon, were specific for C. albicans. Although the ACT sequence is highly conserved among eukaryotes and much more so among Candida species (17), the combination of PCR and hybridization at a high annealing temperature enhanced the specificities of the reagents in the LC system.
The quantity of ACT mRNA is related to the residual population of metabolically active yeasts, as evidenced by a decrease in signal per milligram of skin as the amount of the antimycotic agent applied to the infected skin model increased. However, the population of C. albicans in tissue cannot not be directly estimated from the number of copies of ACT mRNA since the quantity of mRNA in a cell, unlike that of the DNA, is varied and depends on the cellular metabolic state. The absence of C. albicans colonies in Sabouraud dextrose agar cultures of the ACT mRNA-positive skin model, which was treated with 20 µg of amorolfine, may be due to the inhibitory effect of residual drug in tissue.
In conclusion, quantification of ACT mRNA by the LC system represents a sensitive, specific, rapid, and quantitative means of assessing the viability of fungi in an infected tissue. The fact that the average assay time from sample preparation through postamplification analysis was less than 4 h, compared to 24 to 48 h for traditional Candida culture results, underscores the ACT-LC combination potential for rapid evaluation of the viability of fungi in tissue and assessment of the therapeutic efficacies of antifungal drugs in the treatment of fungal diseases.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Dermatology, Juntendo University School of Medicine 2-1-1 Hongo, Bunkyo-ku, Tokyo 113, Japan. Phone: 81-03-5802-1089. Fax: 81-03-3813-9443. E-mail: tsuboi{at}med.juntendo.ac.jp.
| |
REFERENCES |
|---|
|
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
|
|---|
| 1. |
Altschul, S. F.,
T. L. Madden,
A. A. Schäffer,
J. Zhang,
Z. Zhang,
W. Miller, and D. J. Lipman.
1997.
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.
Nucleic Acids Res.
25:3389-3402 |
| 2. |
Barkan, A.
1989.
Tissue-dependent plastid mRNA splicing in maize: transcripts from four plastid genes are predominantly unspliced in leaf meristems and roots.
Plant Cell
1:437-445 |
| 3. |
Donnelly, S. M.,
D. J. Sullivan,
D. B. Shanley, and D. C. Coleman.
1999.
Phylogenetic analysis and rapid identification of Candida dubliniensis based on analysis of ACT1 intron and exon sequences.
Microbiology
145:1871-1882 |
| 4. | Einsele, H., H. Herbert, G. Roller, J. Loeffler, I. Rothenhofer, C. A. Muller, R. A. Bowden, J.-A. van Burik, D. Engelhard, L. Kanz, and U. Schumacher. 1997. Detection and identification of fungal pathogens in blood by using molecular probes. J. Clin. Microbiol. 35:1353-1360[Abstract]. |
| 5. |
Flauhaut, M.,
D. Sanglard,
M. Monod,
J. Bille, and M. Rossier.
1998.
Rapid detection of Candida albicans in clinical samples by DNA amplification of common regions from C. albicans-secreted aspartic proteinase genes.
J. Clin. Microbiol.
36:395-401 |
| 6. | Hennessey, D., D. R. Drummond, and J. C. Sparrow. 1993. Molecular genetics of actin function. Biochem. J. 282:657-671. |
| 7. | Kan, V. L. 1993. Polymerase chain reaction for the diagnosis of candidemia. J. Infect. Dis. 168:779-783[Medline]. |
| 8. |
Kappe, R.,
C. N. Okeke,
C. Fauser,
M. Maiwald, and H.-G. Sonntag.
1998.
Molecular probes for the detection of pathogenic fungi in the presence of human tissue.
J. Med. Microbiol.
47:811-820 |
| 9. |
Kaucner, C., and T. Stinear.
1998.
Sensitive and rapid detection of viable Giardia cysts and Cryptosporidium parvum oocysts in large-volume water samples with wound fiberglass cartridge filters and reverse transcription-PCR.
Appl. Environ. Microbiol.
64:1743-1749 |
| 10. |
Loeffler, J.,
N. Henke,
H. Herbert,
D. Schmidt,
L. Hagemeyer,
U. Schumacher, and H. Einsele.
2000.
Quantification of fungal DNA by using fluorescence resonance energy transfer and the light cycler system.
J. Clin. Microbiol.
38:586-590 |
| 11. |
Maher, N.,
S. Vermund,
M. Lasbury,
C.-H. Lee,
M. Bartlett, and T. R. Unnasch.
2000.
Development and evaluation of a molecular viability assay for Pneumocystis carinii.
J. Clin. Microbiol.
38:1947-1952 |
| 12. | Melchinger, W., A. Polak, and J. Müller. 1988. The effects of amorolfine and oxiconazole on the ultrastructure of Trichophyton mentagrophytes. A comparison. Mycoses 33:393-404. |
| 13. |
Okeke, C. N.,
R. Tsuboi,
M. Kawai, and H. Ogawa.
2000.
Fluorometric assessment of in vitro antidermatophytic activities of antimycotics based on their keratin-penetrating power.
J. Clin. Microbiol.
38:489-491 |
| 14. | Okeke, C. N., R. Tsuboi, M. Kawai, M. Yamazaki, S. Reangchainam, and H. Ogawa. 2000. Reverse transcription-3' rapid amplification of cDNA ends-nested PCR of ACT1 and SAP2 as a means of detecting viable Candida albicans in an in vitro cutaneous candidiasis model. J. Investig. Dermatol. 114:95-100[CrossRef][Medline]. |
| 15. | Reisler, E. 1993. Actin molecular structures and functions. Curr. Opin. Cell Biol. 5:41-47[CrossRef][Medline]. |
| 16. |
Sen, K.
2000.
Rapid identification of Yersinia enterocolitica in blood by the 5' nuclease PCR assay.
J. Clin. Microbiol.
38:1953-1958 |
| 17. | Welch, M. D., D. A. Holtzman, and D. G. Drubin. 1994. The yeast actin cytoskeleton. Curr. Opin. Cell Biol. 6:110-119[CrossRef][Medline]. |
Journal of Clinical Microbiology, October 2001, p. 3491-3494, Vol. 39, No. 10
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.10.3491-3494.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Espy, M. J., Uhl, J. R., Sloan, L. M., Buckwalter, S. P., Jones, M. F., Vetter, E. A., Yao, J. D. C., Wengenack, N. L., Rosenblatt, J. E., Cockerill, F. R. III, Smith, T. F.
(2006). Real-Time PCR in Clinical Microbiology: Applications for Routine Laboratory Testing. Clin. Microbiol. Rev.
19: 165-256
[Abstract] [Full Text] -
Rohrer, M. S., Lazio, M. P., Seifert, H. S.
(2005). A real-time semi-quantitative RT-PCR assay demonstrates that the pilE sequence dictates the frequency and characteristics of pilin antigenic variation in Neisseria gonorrhoeae. Nucleic Acids Res
33: 3363-3371
[Abstract] [Full Text] -
Amjad, M., Kfoury, N., Cha, R., Mobarak, R.
(2004). Quantification and assessment of viability of Cryptococcus neoformans by LightCycler amplification of capsule gene mRNA. J Med Microbiol
53: 1201-1206
[Abstract] [Full Text] -
Frade, J. P., Warnock, D. W., Arthington-Skaggs, B. A.
(2004). Rapid Quantification of Drug Resistance Gene Expression in Candida albicans by Reverse Transcriptase LightCycler PCR and Fluorescent Probe Hybridization. J. Clin. Microbiol.
42: 2085-2093
[Abstract] [Full Text] -
Beggs, K. T., Holmes, A. R., Cannon, R. D., Rich, A. M.
(2004). Detection of Candida albicans mRNA in Archival Histopathology Samples by Reverse Transcription-PCR. J. Clin. Microbiol.
42: 2275-2278
[Abstract] [Full Text] -
Mullick, A., Elias, M., Harakidas, P., Marcil, A., Whiteway, M., Ge, B., Hudson, T. J., Caron, A. W., Bourget, L., Picard, S., Jovcevski, O., Massie, B., Thomas, D. Y.
(2004). Gene Expression in HL60 Granulocytoids and Human Polymorphonuclear Leukocytes Exposed to Candida albicans{dagger}. Infect. Immun.
72: 414-429
[Abstract] [Full Text] -
Long, C. D., Tobiason, D. M., Lazio, M. P., Kline, K. A., Seifert, H. S.
(2003). Low-Level Pilin Expression Allows for Substantial DNA Transformation Competence in Neisseria gonorrhoeae. Infect. Immun.
71: 6279-6291
[Abstract] [Full Text]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»